Exelixis Inc
EXEL: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$24.20 | Pfsm | Hcksbtdr |
Exelixis Reports Q4 Results in Line With Expectations; Maintaining $18.90 FVE, Shares Fairly Valued
Exelixis reported fourth-quarter results in line with our expectations, highlighted by quarterly revenue of nearly $424 million and full-year revenue of $1.6 billion, representing a 12% increase from the prior year. Exelixis is tracking our expectations, and we maintain our fair value estimate of $18.90 per share, no-moat rating, stable moat trend, and High Uncertainty Rating. We view shares as fairly valued, currently trading in 3-star territory.